Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 1999

View Archived Issues

Disappointing results in colorectal cancer patients treated with ledoxantrone

Sugen speeds development of lead angiogenesis inhibitor

Asta Medica files for approval of LHRH antagonist and establishes marketing partnership

Substance P antagonist reduces pain in dental surgery patients

Human mindin polypeptides and polynucleotides for angiogenic diseases

Licensing opportunity from RCT: VZV subunit vaccine

Mitsubishi sets up marketing network for cholesterol-binding agent; launch anticipated this year

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Kyowa Hakko expands R&D activities overseas

Cephalosporin prepared by Korean research team shows promise as lead for further optimization

Toyama, Showa expand periodontitis collaboration

Mechanism of hypoglycemic activity of YM-268 investigated further

Independent panel recommends that pivotal Flocor trial for sickle cell crisis proceed

German academics uncover hormonal mechanism involved in sleep-wake cycles

Provir to be provided to certain AIDS patients in open-label trial

CPMP recommends approval of higher dosage form of Rebif

Telik and Cor Therapeutics enter drug screening and licensing agreement

FDA advisory panel recommends conditional approval of first nonlaser surgical treatment for myopia

Development of cancer treatments targeting apoptosis focus of Idun-Abbott agreement

Extensive toxicity testing conducted on HMG-CoA reductase inhibitor

Medarex and Centeon begin phase II study of MDX-33 as ITP treatment

New antifungal agent approved for marketing in The Netherlands

TKT and Sumitomo collaborate to commercialize Fabry's disease treatment in Asia

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Another cancer indication targeted for Genta's G-3139: non-Hodgkin's lymphoma

IntraBiotics begins phase II clinical trial of ramoplanin ointment

Traditional Chinese medicine shows potential as Rx for hypercholesterolemia

Results presented from early clinical study of naked gene transfer as therapy for angina

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...